(USD) | Dec 2023 | Q/Q |
---|---|---|
Revenue | 324.5MM | +3% |
Gross Profit | 150.5MM | +6% |
Cost Of Revenue | 174MM | +1% |
Operating Income | 33.6MM | -4% |
Operating Expenses | 116.9MM | +9% |
Net Income | 27.6MM | +7% |
R&D | 21.6MM | +10% |
G&A | 95.8MM | +10% |
Amortization | 15MM | -3% |
Interest Expense | 5MM | +3% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BDX vs. MMSI: Which Stock Is the Better Value Option?
Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
While Merit Medical Systems, Inc. ( NASDAQ:MMSI ) might not have the largest market cap around , it saw significant...
BDX vs. MMSI: Which Stock Is the Better Value Option?
Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Merit Medical (MMSI) announces the launch of its latest FDA-approved Micro ACE Advanced Micro-Access System, which is likely to benefit interventional treatments using micro access.
Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging casesSOUTH JORDAN, Utah, March 19, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced commercial release of its US Food and Drug Administration (FDA)-cleared Micro ACE Advanced Micro-Access System. Merit also intends to file Micro ACE for CE mark designation. The Micro ACE system is the latest innovation in t